🚀 VC round data is live in beta, check it out!
- Public Comps
- Adiuvo Investments
Adiuvo Investments Valuation Multiples
Discover revenue and EBITDA valuation multiples for Adiuvo Investments and similar public comparables like Luxbright, PEPTONIC medical, Milton Essex, BBS-Bioactive Bone and more.
Adiuvo Investments Overview
About Adiuvo Investments
Adiuvo Investments SA is engaged in the selection, development, financing and commercialization of projects in the international market. The new technologies developed by the company focus on disease management, monitoring healthy lifestyle and treatment with the help of mobile devices and supplementation and functional food, or food, which in addition to nutritional properties also has health properties.
Founded
2013
HQ

Employees
20
Website
Sectors
Financials (FY)
EV
$9M
Adiuvo Investments Financials
Adiuvo Investments reported last fiscal year revenue of $93K and negative EBITDA of ($490K).
In the same fiscal year, Adiuvo Investments generated $89K in gross profit, ($490K) in EBITDA losses, and had net loss of ($776K).
Adiuvo Investments P&L
In the most recent fiscal year, Adiuvo Investments reported revenue of $93K and EBITDA of ($490K).
Adiuvo Investments expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $93K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $89K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 96% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($490K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (527%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (624%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($776K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (835%) | XXX | XXX | XXX |
| Net Debt | — | — | $6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Adiuvo Investments Stock Performance
Adiuvo Investments has current market cap of $2M, and enterprise value of $9M.
Market Cap Evolution
Adiuvo Investments' stock price is $0.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9M | $2M | 0.1% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAdiuvo Investments Valuation Multiples
Adiuvo Investments trades at 101.7x EV/Revenue multiple, and (19.3x) EV/EBITDA.
Adiuvo Investments Financial Valuation Multiples
As of April 20, 2026, Adiuvo Investments has market cap of $2M and EV of $9M.
Equity research analysts estimate Adiuvo Investments' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Adiuvo Investments has a P/E ratio of (2.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $9M | XXX | $9M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 101.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (19.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (16.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 106.2x | XXX | XXX | XXX |
| P/E | — | XXX | (2.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (9.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Adiuvo Investments Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Adiuvo Investments Margins & Growth Rates
Adiuvo Investments' revenue in the last fiscal year declined by (66%).
Adiuvo Investments' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Adiuvo Investments Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (66%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (527%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (84%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 720% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Adiuvo Investments Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Adiuvo Investments | XXX | XXX | XXX | XXX | XXX | XXX |
| Luxbright | XXX | XXX | XXX | XXX | XXX | XXX |
| PEPTONIC medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Milton Essex | XXX | XXX | XXX | XXX | XXX | XXX |
| BBS-Bioactive Bone | XXX | XXX | XXX | XXX | XXX | XXX |
| Invent Medic Sweden | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Adiuvo Investments M&A Activity
Adiuvo Investments acquired XXX companies to date.
Last acquisition by Adiuvo Investments was on XXXXXXXX, XXXXX. Adiuvo Investments acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Adiuvo Investments
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAdiuvo Investments Investment Activity
Adiuvo Investments invested in XXX companies to date.
Adiuvo Investments made its latest investment on XXXXXXXX, XXXXX. Adiuvo Investments invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Adiuvo Investments
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Adiuvo Investments
| When was Adiuvo Investments founded? | Adiuvo Investments was founded in 2013. |
| Where is Adiuvo Investments headquartered? | Adiuvo Investments is headquartered in Poland. |
| How many employees does Adiuvo Investments have? | As of today, Adiuvo Investments has over 20 employees. |
| Is Adiuvo Investments publicly listed? | Yes, Adiuvo Investments is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Adiuvo Investments? | Adiuvo Investments trades under ADV ticker. |
| When did Adiuvo Investments go public? | Adiuvo Investments went public in 2015. |
| Who are competitors of Adiuvo Investments? | Adiuvo Investments main competitors are Luxbright, PEPTONIC medical, Milton Essex, BBS-Bioactive Bone. |
| What is the current market cap of Adiuvo Investments? | Adiuvo Investments' current market cap is $2M. |
| What is the current revenue of Adiuvo Investments? | Adiuvo Investments' last fiscal year revenue is $93K. |
| What is the current EV/Revenue multiple of Adiuvo Investments? | Current revenue multiple of Adiuvo Investments is 101.7x. |
| Is Adiuvo Investments profitable? | No, Adiuvo Investments is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.